Medical marijuana and the law

New England Journal of Medicine

Volumn 362, Issue 16, 2010, Pages 1453-1457

  Hoffmann, Diane E ^a   Weber, Ellen ^a  

^a UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABIS;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CACHEXIA; CANNABIS ADDICTION; CAREGIVER; CHRONIC PAIN; COURT; CRIME; CROHN DISEASE; DOCTOR PATIENT RELATION; DRUG CONTROL; DRUG LEGISLATION; DRUG PURITY; DRUG QUALITY; EPILEPSY; EVIDENCE BASED PRACTICE; FOOD AND DRUG ADMINISTRATION; GLAUCOMA; GOVERNMENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEDICAL DOCUMENTATION; MEDICAL RESEARCH; MEDICAL SOCIETY; MULTIPLE SCLEROSIS; MUSCLE SPASM; NAUSEA; NEOPLASM; PATIENT ADVOCACY; POLICY; PRESCRIPTION; PRIORITY JOURNAL; REGISTER; SEIZURE; SHORT SURVEY; STANDARD; UNITED STATES;

EID: 77951486401     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp1000695     Document Type: Short Survey

References (4)

1. ProCon.org. 14 Legal medical marijuana states: laws, fees and possession limits. (Accessed April 1, 2010, at http://medicalmarijuana.procon.org/view. resource.php?resourceID=000881.)
2. Taylor T. Supporting research into the therapeutic role of marijuana. Position paper. New York: American College of Physicians, 2008. (Accessed April 1, 2010, at http://proxychi.baremetal.com/csdp.org/research/medmarijuana.pdf.)
3. Use of cannabis for medicinal purposes, report 3 of the Council on Science and Public Health (I-09). Chicago: American Medical Association, 2009. (Accessed April 1, 2010, at http://www.ama-assn.org/ama1/pub/upload/mm/443/ csaph-report3-i09.pdf.)
4. Degenhardt L, Hall WD. The adverse effects of cannabinoids: implications for use of medical marijuana. CMAJ 2008;178: 1685-1686